Accesos endovenosos utilizados para la Nutrición Parenteral
Texto completo:
PDFResumen
Palabras clave
Referencias
Fontenot C, O’Leary JP. Dr. Werner Forssman’s self-experimentation. Am Surg 1996;62: 514-5.
Sourkes TL. Nobel Prize Winners in Medicine and Physiology, 1901-1965 (Editores: Abelhard & Schuman). London: 1967.
Aubaniac R. L’ Injection intravense sous claviculare: Adventaje et techique. Press Med 1952; 60:1956.
Wilson JN, Grow JB. Central venous pressure in optimal blood volume maintenance. Arch Surg 1982;85:563-78.
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography (a new technique). Acta Radiol (Stockh) 1953:39:368-76.
Rhoads JE, Steiger E, Dudrick SJ, Long JM. Intravenous hyper-alimentation. Med Clin North Am 1970;54:577-89.
Wilmore DW, Dudrick SJ. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA 1968;203:860-4.
Scribner BH, Cole JJ, Christopher TG, Vizzo JE, Atkins RC, Blagg CR. Long-Term Total Parenteral Nutrition. The concept of an artificial gut. JAMA 1970;212:457-63.
Ryder M. The future of vascular access: Will the benefits be worth the risk? [Editorial]. Nutr Clin Pract 1999;14: 165-9.
Orr ME. Vascular access devices selection for parenteral nutrition. Nutr Clin Pract 1999; 14:172-7.
Perrigault PF, Jaber S, Eledjam JJ. Catheter-related infections: How to reduce the risk? Ann Fr Anesth Reanim 2005;24:288-90.
Anónimo. Guidelines for preventing infections associated with the insertion and maintenance of central venous catheters. J Hosp Infect 2001;47(Suppl):S47- S67.
Ryan DW. Lymph leakage following catheterization of the right subclavian vein. Anesth Analg 1978;57:123-4.
Friedman B, Kanter G, Titus D. Femoral venous catheters: A safe alternative for delivering parenteral alimentation. Nutr Clin Pract 1994;9:69-72.
Harden JL, Kemp L, Mirtallo J. Femoral catheters increase risk of infection in total parenteral nutrition patients. Nutr Clin Pract 1995;10:60-6.
Joynt GM, Kew J, Gomersall CD, Leung VYF, Liu EKH. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 2000;117:118-83.
Vanek VW. The ins and outs of venous access: part I. Nutr Clin Pract 2002; 17:85-98.
Vanek VW. The ins and outs of venous access: part II. Nutr Clin Pract 2002; 17:142-55.
Pieters PC, Tiznado J, Mauro MA. Venous catheters: A practical manual. Thieme Medical Publishers, Inc. New York: 2003.
Lowell JA, Bothe A. Venous accesses preoperative, operative and post-operative dilemmas. Surg Clin North Am 1991;71:1231-46.
Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related blood stream infection by use of an antiseptic-impregnated catheter. A randomized controlled trial. Ann Intern Med 1997;127:257-66.
Haxhe JJ, D'Hoore W. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sulfadiazine impregnated central venous catheters. J Hosp Infect 1998;40:166-8.
Korbila IP, Bliziotis IA, Lawrence KR, Falagas ME. Antibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence. Expert Rev Anti Infect Ther 2007;5:639-52.
Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C; et al. Sodium citrate versus heparin catheters locks for cuffed central venous catheters: a single- center, randomized controlled trial. Am J Kidney Dis 2009;53:1034-41.
Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anestehesiology 1997;87:1242-44.
Garrelts JC. White clot syndrome and thrombocytopenia: reasons to abandon heparin IV lock flush solution. Clin Pharmacol 1992;11:797-9.
Hoshal VL. Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg 1975;110:644-6.
Groshong LE, Brawn RJ. Methods and apparatus for intravenous therapy and hyperalimentation. US Patent 4431426. Febrero de 1984. Disponible en: http://www.freepatentsonline.com/4431426.html. Fecha de última visita: 25 de Abril del 2009.
East SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. J Intraven Nurs 1994;17:189-92 .
Larsen E. Guidelines for use of topical antimicrobial agents. Am J Infect Control 1988;16:253-66.
Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlor-hexidine for prevention of infection associated with central venous and arterial catheters. The Lancet 1991;338:339-43.
Pearson ML. HICPAC Hospital Infection Control Practices Advisory Committee. Guidelines for prevention of intravascular device-related infections. Infect Control Hosp Epidemiol 1996;17:438-73.
Mermel LA. Prevention of intravascular catheter-related infections. Ann Inter Med 2000;132:391-402.
Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993;167:487-90.
Sitges Serra A, Linares J, Pérez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985;9:322-5.
Raad I, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA; et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994;15:231-8.
Knittle MA, Eitzman DV, Baer H. Role of hand contamination of personnel in the epidemiology of gram-negative nosocomial infections. J Pediatr 1975;86:433-7.
Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointment in prevention of vascular catheter-related infection. Am J Med 1981;70:739-44.
Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor transparent dressing. JAMA 1987;258: 2396-403.
Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1992;22:1729-37.
Weber DR. Is heparin really necessary in the lock and, if so, how much? Drugs Intelligence and Clinical Pharmacy Annals of Pharmacotherapy 1991;25:399-407.
Goetz A, Wagener M, Miller J, Muder R. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998;19:842-5.
Lee RB, Buckner M, Sharp KW. Do multi-lumen catheters increase central venous catheter sepsis compared to single catheters? J Trauma 1988;28: 1472-5.
Bull DA, Neumayer LA, Hunter GC, Sethi GK, McIntyre KE, Bernhard VM, Putnam CW. Improved sterile technique diminishes the incidence of positive line cultures in cardiovascular patients. J Surg Res 1992;52:106-10.
CDC Centers for Disease Control and Prevention. Update: Universal precautions for prevention of transmission of HIV, Hepatitis B, and other bloodborne pathogens in healthcare settings. MMWR 1988;24: 377-82, 387-8.
Raad I, Baba M, Bodey GP. Diagnosis of catheter-related infections: role of the surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995;20:593-7.
Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993;31: 475-9.
Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- versus 72-hour intervals. 72 hours is safe and cost effective. JAMA 1987;258:1777-1781.
Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985; 6:367-70.
Vasilakis A, Apelgren KN. Answering the fat emulsion question: Three in one admixture versus conventional total parenteral nutrition in a clinical setting. JPEN J Parenter Enteral Nutr 1988;12:356-9.
Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol 1984;19:17-20.
Bock SN, Lee RE, Fisher B, Rubin JT, Schwartzentruber DJ, Wei JP.; et al. A prospective randomised trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy. J Clin Oncol 1990;8:161-9.
Cobb DK, High KP, Sawyer RG, Sable CA, Adams RB, Lindley DA; et al. A controlled trial of scheduled replacement of central venous and pulmonary artery catheters. N Engl J M 1992;237:1062-8.
Armstrong CW, Mayhall CG, Miller KB, Newsome Jr HH, Sugerman HJ, Dalton HP; et al. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986;154:808-16.
Snyder RH, Archer FJ, Endy T, Allen T W, Condon B, Kaiser, J; et al. Catheter infection. A comparison of two catheter maintenance techniques. Ann Surg 1988;208:651-3.
O´Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG; et al; for the Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. CID 2002;35:1281-1307.
O´Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J; et al. ICSA/SCCM Practice guidelines for evaluating new fever in critically ill adult patients. CID 1998;26:1042-59.
Michel LA, Bradpiece HA, Randour P, Pouthier F. Safety of central venous catheter change over a guide wire for suspected catheter-related sepsis: a prospective randomised trial. Int Surg 1988;73:180-6.
Ferraresi Zarranz EM. Complicaciones infecciosas en la Nutrición parenteral. Revista del ITAES Instituto Técnico para la Acreditación de Establecimientos de Salud [Argentina] 2008;10:20-33.
Kemp L, Burge J, Choban P, Harden J, Mirtallo J, Flancbaum L. The effect of catheter type and site on infection rates in total parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1994;18: 71-4.
Enlaces refback
- No hay ningún enlace refback.
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.